Market Research Report

Global Genetic Engineering Plant Genomics Market Insights, Size, and Forecast By Technique (CRISPR, Transgenic Technology, Gene Cloning, RNA Interference, Genome Sequencing), By End Use (Agriculture, Research & Development, Commercial Production), By Organism Type (Cereals, Vegetables, Fruits, Flowers, Trees), By Application (Crop Improvement, Disease Resistance, Stress Tolerance, Nutritional Enhancement, Biopesticide Development), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:20613
Published Date:Jan 2026
No. of Pages:229
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Genetic Engineering Plant Genomics Market is projected to grow from USD 12.8 Billion in 2025 to USD 33.5 Billion by 2035, reflecting a compound annual growth rate of 11.8% from 2026 through 2035. This market encompasses the application of advanced genetic engineering and genomic technologies to enhance plant traits, improve crop yield, increase disease resistance, and develop novel plant-based products. It leverages a deep understanding of plant genomes to precisely modify genes, leading to more resilient and productive agricultural systems. Key market drivers include the escalating global demand for food, feed, and biofuels, driven by a growing population and evolving dietary preferences. The increasing adoption of genetically modified crops due to their proven benefits in reducing pesticide use and improving nutritional content further fuels market expansion. Additionally, significant advancements in gene editing tools like CRISPR-Cas9, next-generation sequencing, and bioinformatics are accelerating research and development, making genetic engineering more precise, efficient, and cost-effective.

Global Genetic Engineering Plant Genomics Market Value (USD Billion) Analysis, 2025-2035

maklogo
11.8%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

A significant trend observed in the market is the increasing focus on sustainable agriculture and climate-resilient crops. Researchers and companies are leveraging genetic engineering to develop plants that can thrive in harsh environmental conditions, such as drought, salinity, and extreme temperatures. Another important trend is the expansion beyond traditional row crops into specialty crops, ornamentals, and even medicinal plants, opening new avenues for product development. However, the market faces restraints such as stringent regulatory frameworks and public skepticism surrounding genetically engineered organisms. Concerns regarding potential environmental impacts and consumer acceptance of GMO products continue to pose challenges, leading to varying levels of market penetration across different regions. Opportunities abound in the development of nutrient-fortified crops to address global malnutrition, the creation of plants for pharmaceutical production (pharming), and the engineering of biomass crops for renewable energy. The integration of artificial intelligence and machine learning for predictive genomics and trait selection also presents a lucrative opportunity for market players.

North America currently holds the dominant position in the global market, driven by substantial research and development investments, a robust biotechnology infrastructure, and a supportive regulatory environment for commercializing genetically engineered crops. The presence of numerous key market players and academic institutions engaged in cutting-edge plant genomics research further solidifies its leading position. Conversely, Asia Pacific is anticipated to be the fastest-growing region, propelled by increasing population pressure, growing food security concerns, and rising government initiatives to modernize agriculture and adopt advanced biotechnologies. The expanding research capabilities and a shift towards agricultural self-sufficiency in countries like China and India are significant contributors to this rapid growth. Key players in this competitive landscape include BASF, Phytocoris, Dow AgroSciences, Calyxt, Invitae, Thermo Fisher Scientific, Corteva, DuPont, Syngenta, and Genomatica. These companies are strategically investing in research and development, forming collaborations, and focusing on product innovation, particularly in gene editing technologies and crop trait development, to maintain and expand their market share. The Crop Improvement segment stands out as the leading application, underscoring the primary focus of genetic engineering in enhancing agricultural productivity and resilience.

Quick Stats

  • Market Size (2025):

    USD 12.8 Billion
  • Projected Market Size (2035):

    USD 33.5 Billion
  • Leading Segment:

    Crop Improvement (42.5% Share)
  • Dominant Region (2025):

    North America (38.2% Share)
  • CAGR (2026-2035):

    11.8%

What is Genetic Engineering Plant Genomics?

Genetic Engineering Plant Genomics integrates modifying plant genomes with studying their complete genetic makeup. It involves precisely altering specific genes within plants to introduce desirable traits, like enhanced yield or disease resistance. Simultaneously, it leverages genomics tools to map, sequence, and analyze the entire set of genes in a plant. This comprehensive understanding of a plant’s genetic blueprint allows for targeted modifications. The significance lies in developing improved crop varieties through informed genetic manipulation, accelerating breeding programs, and creating plants resilient to environmental stresses. Applications include developing herbicide tolerant crops, nutrient enhanced foods, and plants producing pharmaceuticals, revolutionizing agriculture and biotechnology.

What are the Key Drivers Shaping the Global Genetic Engineering Plant Genomics Market

  • Advancements in Gene Editing Technologies (CRISPR, TALENs, ZFNs)

  • Increasing Demand for Enhanced Crop Yield and Resilience

  • Growing Investment in Agricultural Biotechnology and R&D

  • Expanding Applications in Biofuel Production and Industrial Biotechnology

  • Favorable Regulatory Landscape and Public Acceptance of GMOs

Advancements in Gene Editing Technologies (CRISPR, TALENs, ZFNs)

Advancements in gene editing technologies like CRISPR TALENs and ZFNs are revolutionizing plant genomics. These precision tools enable scientists to make targeted modifications to plant DNA with unprecedented accuracy and efficiency. CRISPR Clustered Regularly Interspaced Short Palindromic Repeats in particular has emerged as a game changer due to its simplicity versatility and cost effectiveness. It allows for precise insertion deletion or alteration of genes to introduce desirable traits such as enhanced disease resistance herbicide tolerance improved nutritional value and increased yield. This capability accelerates crop breeding cycles and facilitates the development of novel plant varieties tailored to specific environmental conditions and consumer demands driving innovation and expansion within the global genetic engineering plant genomics market.

Increasing Demand for Enhanced Crop Yield and Resilience

The global population continues to expand, intensifying the need for sustainable and efficient food production. This increasing demand for enhanced crop yield and resilience is a primary driver in the genetic engineering plant genomics market. Traditional breeding methods often struggle to keep pace with evolving environmental challenges like climate change, new diseases, and pest infestations, which severely impact agricultural productivity. Genetic engineering offers precise tools to introduce desirable traits into crops, such as drought tolerance, disease resistance, improved nutritional value, and higher yields per acre. Farmers, facing pressure to produce more with less land and resources, are actively seeking these advanced solutions. This drives investment in plant genomics research and development, accelerating the adoption of genetically modified crops and gene editing technologies to secure global food supply and agricultural sustainability.

Growing Investment in Agricultural Biotechnology and R&D

Growing investment in agricultural biotechnology and research and development is a crucial driver for the Global Genetic Engineering Plant Genomics Market. Increased funding from both public and private sectors fuels the exploration and application of advanced genomic technologies to enhance crop characteristics. This investment supports the development of new genetically modified plant varieties with improved resistance to pests and diseases, enhanced nutritional content, and better adaptation to climate change. Companies and research institutions are allocating more resources to gene editing tools like CRISPR CAS9, bioinformatics, and high throughput phenotyping. This commitment accelerates innovation, expands the pipeline of commercialized genetically engineered crops, and ultimately drives market expansion by addressing global food security and sustainability challenges.

Global Genetic Engineering Plant Genomics Market Restraints

Ethical Concerns and Public Opposition to Genetic Modification

Widespread ethical concerns and public opposition significantly impede the global genetic engineering plant genomics market. These reservations stem from fears about altering natural ecosystems, potential unforeseen long term health impacts on consumers, and the perceived “playing God” aspect of manipulating genetic material. Many individuals and organizations express moral objections to genetically modified organisms (GMOs), arguing for a right to natural, unaltered food sources. This societal resistance manifests in consumer boycotts, strong advocacy group campaigns, and a general lack of trust in biotech companies. Consequently, companies face hurdles in obtaining regulatory approvals, encounter resistance to product adoption, and struggle with negative public perception, all of which constrain market growth and innovation.

Stringent Regulatory Frameworks and Approval Processes for GMOs

Stringent regulatory frameworks and approval processes for genetically modified organisms (GMOs) act as a significant restraint in the global genetic engineering plant genomics market. These frameworks necessitate extensive research, rigorous testing, and lengthy evaluation periods to ensure the safety and efficacy of novel GM crops. Companies must navigate complex legal landscapes, often varying considerably across different countries and regions, which demand substantial financial and human resources. The protracted nature of these approvals delays market entry for innovative products, increasing development costs and investment risks. Furthermore, the uncertainty inherent in a multi-jurisdictional approval system can deter new entrants and limit the scope of research and development efforts, hindering the overall growth and expansion of the market for genetically engineered plants.

Global Genetic Engineering Plant Genomics Market Opportunities

Precision Genetic Engineering for Climate-Resilient and Nutritionally Enhanced Crop Varieties

The opportunity in precision genetic engineering lies in leveraging advanced genomic tools to develop crop varieties critical for global food security. By precisely modifying plant genomes, scientists can create crops inherently more resilient to the escalating challenges of climate change, such as drought, floods, heatwaves, and emerging pests. This involves engineering traits like enhanced water use efficiency, heat tolerance, and disease resistance directly into staple foods. Simultaneously, these same precise techniques allow for the biofortification of crops, significantly boosting their nutritional content. Addressing widespread micronutrient deficiencies and improving human health globally presents an immense market demand. Particularly in rapidly developing agricultural regions, there is a profound need for high yielding, sustainable, and nutritious food sources. This dual focus on resilience and nutrition directly translates into a significant, high impact commercial opportunity within the global genetic engineering plant genomics sector, promising sustainable agricultural solutions and improved public health outcomes worldwide.

Harnessing Plant Genetic Engineering for Sustainable Bio-Industrial Feedstocks and Novel Bioproducts

This compelling opportunity centers on utilizing sophisticated plant genetic engineering to revolutionize industrial inputs and create breakthrough bioproducts. By precisely altering plant genomes, scientists can design crops specifically to function as highly efficient, sustainable bio industrial feedstocks. This means developing plants optimized for superior biomass accumulation, enhanced nutrient uptake, or the high yield production of specific molecules required for biofuels, biodegradable plastics, and essential biochemicals, thereby significantly lessening dependence on fossil resources. Beyond basic feedstocks, genetic engineering empowers the creation of novel bioproducts directly within the plant itself. This includes developing plants that synthesize therapeutic proteins, vaccines, specialized industrial enzymes, or high value nutraceuticals, offering greener, more scalable, and often more cost effective production methods. The global landscape, particularly rapidly expanding economies in Asia Pacific, exhibits a profound demand for such innovative, plant derived solutions. This paradigm shift positions plants as versatile biofactories, driving a sustainable bioeconomy across energy, materials, and healthcare sectors, fostering environmental benefits and new economic avenues.

Global Genetic Engineering Plant Genomics Market Segmentation Analysis

Key Market Segments

By Application

  • Crop Improvement
  • Disease Resistance
  • Stress Tolerance
  • Nutritional Enhancement
  • Biopesticide Development

By Technique

  • CRISPR
  • Transgenic Technology
  • Gene Cloning
  • RNA Interference
  • Genome Sequencing

By Organism Type

  • Cereals
  • Vegetables
  • Fruits
  • Flowers
  • Trees

By End Use

  • Agriculture
  • Research & Development
  • Commercial Production

Segment Share By Application

Share, By Application, 2025 (%)

  • Crop Improvement
  • Disease Resistance
  • Stress Tolerance
  • Nutritional Enhancement
  • Biopesticide Development
maklogo
$12.8BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is Crop Improvement dominating the Global Genetic Engineering Plant Genomics Market?

Crop Improvement holds the largest share due to the urgent global need for enhanced food security and agricultural productivity. Genetic engineering in this segment directly addresses challenges such as feeding a growing population, increasing yield per acre, and improving the nutritional content and quality of staple crops. This focus on fundamental agricultural needs makes it a primary investment area for research and development, providing significant returns for farmers and food producers worldwide.

Which technique is significantly influencing advancements within the Global Genetic Engineering Plant Genomics Market?

CRISPR technology is revolutionizing the plant genomics market by offering unparalleled precision and efficiency in gene editing. Its ease of use and ability to target specific genes allow researchers to swiftly develop new plant varieties with desired traits like enhanced disease resistance or stress tolerance. This powerful technique is accelerating innovation across various applications, reducing development timelines, and enabling breakthroughs that were previously difficult or impossible with traditional methods.

How do specific End Use sectors shape investment and innovation in genetic engineering plant genomics?

The Agriculture sector drives substantial investment due to its direct impact on food production and economic stability. Farmers and agribusinesses adopt genetically engineered plants for improved yields, pest resistance, and reduced input costs. Concurrently, Research & Development, both academic and commercial, plays a crucial role by pioneering new techniques and traits, forming the foundational knowledge necessary for subsequent commercial production. These sectors are interdependent, with R&D fueling agricultural advancements and agriculture providing the market demand for innovative solutions.

What Regulatory and Policy Factors Shape the Global Genetic Engineering Plant Genomics Market

The global genetic engineering plant genomics market operates within a highly diverse and evolving regulatory framework. Strict regulations for genetically modified organisms GMOs prevail in regions like Europe, mandating extensive safety assessments, traceability, and often requiring clear labeling, which significantly impacts market entry and public acceptance. In contrast, North and South America generally adopt more science based, product focused regulatory approaches, sometimes differentiating between traditional GMOs and newer gene edited crops that do not introduce foreign DNA.

Asian nations present a varied landscape, with countries like China actively promoting biotech research while others maintain cautious import policies. Intellectual property protection, through patents for novel traits and gene editing tools such as CRISPR, is a crucial legal consideration shaping investment and technology transfer. The absence of global regulatory harmonization creates trade barriers and increases compliance costs. Policy evolution, especially concerning precision breeding techniques, seeks to balance innovation with biosafety, profoundly influencing research, product development, and market accessibility worldwide.

What New Technologies are Shaping Global Genetic Engineering Plant Genomics Market?

Innovations are profoundly reshaping the global genetic engineering plant genomics market. Advanced CRISPR Cas systems, including base and prime editing, offer unparalleled precision for targeted gene modification, accelerating the development of crops with enhanced yields, disease resistance, and nutritional profiles. Next generation sequencing and long read technologies are providing comprehensive genomic insights, enabling a deeper understanding of complex plant architectures and genetic variations critical for crop improvement. Artificial intelligence and machine learning are increasingly pivotal for analyzing vast genomic datasets, predicting gene functions, and optimizing breeding strategies. Emerging synthetic biology approaches are facilitating the design of novel metabolic pathways and traits previously unattainable. High throughput phenotyping complements these genomic advancements by efficiently linking specific genes to observable plant characteristics, significantly boosting selection efficiency and accelerating product development.

Global Genetic Engineering Plant Genomics Market Regional Analysis

Global Genetic Engineering Plant Genomics Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
38.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 38.2% share

North America dominates the Global Genetic Engineering Plant Genomics Market with a substantial 38.2% market share. This leadership position is driven by several key factors. The region boasts a strong presence of leading biotechnology companies and agricultural research institutions. Significant investment in research and development, coupled with a robust intellectual property framework, fosters innovation in plant genomics. Additionally, advanced agricultural practices and widespread adoption of genetically engineered crops, particularly in the United States and Canada, contribute to the high demand for genomics solutions. Favorable regulatory environments and substantial government funding for agricultural biotechnology further solidify North America's preeminent role in this rapidly evolving market, establishing it as a critical hub for genetic engineering advancements.

Fastest Growing Region

Asia Pacific · 12.4% CAGR

Asia Pacific emerges as the fastest growing region in the global genetic engineering plant genomics market, projected to expand at a robust CAGR of 12.4% during the forecast period. This rapid growth is fueled by increasing food demand from a burgeoning population, compelling agricultural innovation. Governments across the region are actively investing in research and development for genetically modified crops, aiming to enhance yield, pest resistance, and nutritional value. The expanding biotechnology sector, coupled with a growing number of skilled scientists and improved research infrastructure, further propels market expansion. Additionally, rising awareness regarding the benefits of genomics in sustainable agriculture drives adoption, positioning Asia Pacific at the forefront of this transformative market.

Top Countries Overview

The U.S. is a leader in the global genetic engineering and plant genomics market, driven by robust R&D, venture capital, and supportive regulatory frameworks. Its market focuses on developing resilient, high-yield crops and innovative biotech solutions. However, public perception and international trade regulations present ongoing challenges, yet opportunities for growth remain high.

China is a dominant force in the global genetic engineering and plant genomics market. Its vast agricultural land and strong government support for biotechnology fuel rapid advancements. Chinese researchers are leading in gene editing (CRISPR), functional genomics, and developing stress-resistant, high-yield crops. This robust ecosystem makes China a key player in shaping the future of global food security and agricultural innovation.

India's robust agricultural sector and growing biotech industry position it as a significant player in global genetic engineering and plant genomics. Increased R&D, government initiatives, and private investments are driving the market. Focus areas include improved crop yields, disease resistance, and nutritional enhancement. Strong scientific talent and diverse germplasm resources further solidify India's influence in the international plant genomics landscape, particularly for staple crops.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical tensions significantly influence the Global Genetic Engineering Plant Genomics Market. Trade disputes and protectionist policies among major agricultural nations can disrupt the cross border flow of patented technologies and genetically engineered crops. Regulatory divergence across countries, driven by national security or ethical concerns regarding GMOs, creates market fragmentation and hinders global market penetration. Geopolitical alliances and rivalries further shape research funding priorities and intellectual property sharing agreements, impacting innovation and market leadership. The pursuit of food security independence by nations, often spurred by geopolitical instability, drives domestic investment in advanced plant breeding technologies.

Macroeconomic factors play a crucial role. Fluctuations in agricultural commodity prices directly impact farmers' ability to invest in premium genetically engineered seeds and associated genomics services. Inflationary pressures increase R&D costs for biotechnology companies and raw material expenses for seed production. Currency exchange rate volatility affects the profitability of international sales and the attractiveness of foreign direct investment. Economic recessions can curtail public funding for agricultural research and development, slowing the adoption of innovative genomics solutions. Conversely, strong economic growth in emerging markets expands the addressable market for improved crop varieties.

Recent Developments

  • March 2025

    Corteva and BASF announced a strategic partnership to accelerate the development and commercialization of next-generation herbicide-tolerant soybeans. This collaboration aims to bring new genetic traits to market faster, providing farmers with more resilient and productive crop options.

  • February 2025

    Calyxt received regulatory approval for its new high oleic low linolenic soybean oil, a product developed using advanced gene editing technologies. This approval allows Calyxt to expand its commercial offerings of healthier food ingredients, catering to growing consumer demand for improved nutritional profiles.

  • January 2025

    Thermo Fisher Scientific launched a new high-throughput genomic sequencing platform specifically designed for large-scale plant genomics research. This platform offers enhanced speed and accuracy, enabling researchers to more efficiently identify and characterize genetic variations in diverse plant species.

  • November 2024

    Syngenta acquired a specialized plant breeding technology firm, enhancing its capabilities in precision breeding for climate-resilient crops. This acquisition strengthens Syngenta's portfolio of innovative solutions aimed at addressing global food security challenges through advanced genetic engineering.

  • October 2024

    Dow AgroSciences initiated a new strategic initiative focused on developing drought-tolerant corn varieties using CRISPR-Cas9 gene editing. This multi-year program aims to introduce genetic traits that significantly improve water use efficiency in corn, crucial for regions facing increasing water scarcity.

Key Players Analysis

Leading the Global Genetic Engineering Plant Genomics Market are key players like BASF, Dow AgroSciences, Corteva, Syngenta, and DuPont, driving innovation in crop enhancement and agricultural biotechnology. These giants develop genetically modified seeds for traits like herbicide resistance and increased yield, utilizing advanced genomics and gene editing technologies such as CRISPR. Strategic initiatives include R&D investments, collaborations, and acquisitions to expand product portfolios and market reach. Phytocoris, Calyxt, Invitae, Thermo Fisher Scientific, and Genomatica contribute with specialized tools, services, and niche applications, supporting the broader market growth driven by increasing food demand, climate change challenges, and the need for sustainable agriculture practices.

List of Key Companies:

  1. BASF
  2. Phytocoris
  3. Dow AgroSciences
  4. Calyxt
  5. Invitae
  6. Thermo Fisher Scientific
  7. Corteva
  8. DuPont
  9. Syngenta
  10. Genomatica
  11. Bayer
  12. Ceres Global Ag Corp
  13. Monsanto
  14. Agilent Technologies
  15. Limagrain
  16. KWS SAAT

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 12.8 Billion
Forecast Value (2035)USD 33.5 Billion
CAGR (2026-2035)11.8%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Application:
    • Crop Improvement
    • Disease Resistance
    • Stress Tolerance
    • Nutritional Enhancement
    • Biopesticide Development
  • By Technique:
    • CRISPR
    • Transgenic Technology
    • Gene Cloning
    • RNA Interference
    • Genome Sequencing
  • By Organism Type:
    • Cereals
    • Vegetables
    • Fruits
    • Flowers
    • Trees
  • By End Use:
    • Agriculture
    • Research & Development
    • Commercial Production
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Genetic Engineering Plant Genomics Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.1.1. Crop Improvement
5.1.2. Disease Resistance
5.1.3. Stress Tolerance
5.1.4. Nutritional Enhancement
5.1.5. Biopesticide Development
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Technique
5.2.1. CRISPR
5.2.2. Transgenic Technology
5.2.3. Gene Cloning
5.2.4. RNA Interference
5.2.5. Genome Sequencing
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Organism Type
5.3.1. Cereals
5.3.2. Vegetables
5.3.3. Fruits
5.3.4. Flowers
5.3.5. Trees
5.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
5.4.1. Agriculture
5.4.2. Research & Development
5.4.3. Commercial Production
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Genetic Engineering Plant Genomics Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.1.1. Crop Improvement
6.1.2. Disease Resistance
6.1.3. Stress Tolerance
6.1.4. Nutritional Enhancement
6.1.5. Biopesticide Development
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Technique
6.2.1. CRISPR
6.2.2. Transgenic Technology
6.2.3. Gene Cloning
6.2.4. RNA Interference
6.2.5. Genome Sequencing
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Organism Type
6.3.1. Cereals
6.3.2. Vegetables
6.3.3. Fruits
6.3.4. Flowers
6.3.5. Trees
6.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
6.4.1. Agriculture
6.4.2. Research & Development
6.4.3. Commercial Production
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Genetic Engineering Plant Genomics Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.1.1. Crop Improvement
7.1.2. Disease Resistance
7.1.3. Stress Tolerance
7.1.4. Nutritional Enhancement
7.1.5. Biopesticide Development
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Technique
7.2.1. CRISPR
7.2.2. Transgenic Technology
7.2.3. Gene Cloning
7.2.4. RNA Interference
7.2.5. Genome Sequencing
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Organism Type
7.3.1. Cereals
7.3.2. Vegetables
7.3.3. Fruits
7.3.4. Flowers
7.3.5. Trees
7.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
7.4.1. Agriculture
7.4.2. Research & Development
7.4.3. Commercial Production
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Genetic Engineering Plant Genomics Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.1.1. Crop Improvement
8.1.2. Disease Resistance
8.1.3. Stress Tolerance
8.1.4. Nutritional Enhancement
8.1.5. Biopesticide Development
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Technique
8.2.1. CRISPR
8.2.2. Transgenic Technology
8.2.3. Gene Cloning
8.2.4. RNA Interference
8.2.5. Genome Sequencing
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Organism Type
8.3.1. Cereals
8.3.2. Vegetables
8.3.3. Fruits
8.3.4. Flowers
8.3.5. Trees
8.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
8.4.1. Agriculture
8.4.2. Research & Development
8.4.3. Commercial Production
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Genetic Engineering Plant Genomics Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.1.1. Crop Improvement
9.1.2. Disease Resistance
9.1.3. Stress Tolerance
9.1.4. Nutritional Enhancement
9.1.5. Biopesticide Development
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Technique
9.2.1. CRISPR
9.2.2. Transgenic Technology
9.2.3. Gene Cloning
9.2.4. RNA Interference
9.2.5. Genome Sequencing
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Organism Type
9.3.1. Cereals
9.3.2. Vegetables
9.3.3. Fruits
9.3.4. Flowers
9.3.5. Trees
9.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
9.4.1. Agriculture
9.4.2. Research & Development
9.4.3. Commercial Production
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Genetic Engineering Plant Genomics Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.1.1. Crop Improvement
10.1.2. Disease Resistance
10.1.3. Stress Tolerance
10.1.4. Nutritional Enhancement
10.1.5. Biopesticide Development
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Technique
10.2.1. CRISPR
10.2.2. Transgenic Technology
10.2.3. Gene Cloning
10.2.4. RNA Interference
10.2.5. Genome Sequencing
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Organism Type
10.3.1. Cereals
10.3.2. Vegetables
10.3.3. Fruits
10.3.4. Flowers
10.3.5. Trees
10.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
10.4.1. Agriculture
10.4.2. Research & Development
10.4.3. Commercial Production
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. BASF
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Phytocoris
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Dow AgroSciences
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. Calyxt
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Invitae
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Thermo Fisher Scientific
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Corteva
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. DuPont
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Syngenta
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. Genomatica
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Bayer
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Ceres Global Ag Corp
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Monsanto
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Agilent Technologies
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. Limagrain
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis
11.2.16. KWS SAAT
11.2.16.1. Business Overview
11.2.16.2. Products Offering
11.2.16.3. Financial Insights (Based on Availability)
11.2.16.4. Company Market Share Analysis
11.2.16.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.16.6. Strategy
11.2.16.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 2: Global Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Technique, 2020-2035

Table 3: Global Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Organism Type, 2020-2035

Table 4: Global Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 5: Global Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 7: North America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Technique, 2020-2035

Table 8: North America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Organism Type, 2020-2035

Table 9: North America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 10: North America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 12: Europe Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Technique, 2020-2035

Table 13: Europe Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Organism Type, 2020-2035

Table 14: Europe Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 15: Europe Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 17: Asia Pacific Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Technique, 2020-2035

Table 18: Asia Pacific Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Organism Type, 2020-2035

Table 19: Asia Pacific Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 20: Asia Pacific Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 22: Latin America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Technique, 2020-2035

Table 23: Latin America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Organism Type, 2020-2035

Table 24: Latin America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 25: Latin America Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 27: Middle East & Africa Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Technique, 2020-2035

Table 28: Middle East & Africa Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Organism Type, 2020-2035

Table 29: Middle East & Africa Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 30: Middle East & Africa Genetic Engineering Plant Genomics Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

;